Arcadia Biosciences Inc expected to post a loss of $2.21 a share - Earnings Preview

Arcadia Biosciences

08/05/2024 03:23

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 9 for
the period ending March 31 2024
    * The Davis California-based  company is expected to report
a
20.9% decrease in revenue to $1.194 million from $1.51 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Arcadia Biosciences Inc
is for
a loss of $2.21 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $11.00​, above​ its last closing price
of $2.01. ​​​

This summary was machine generated May 8 at 02:23 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)